Pages that link to "Q34354908"
Jump to navigation
Jump to search
The following pages link to Pharmacological similarities and differences between beta2-agonists (Q34354908):
Displaying 17 items.
- Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. (Q35046032) (← links)
- Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities (Q36443665) (← links)
- Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease (Q37000770) (← links)
- Role of arformoterol in the management of COPD (Q37070335) (← links)
- Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety (Q37115933) (← links)
- Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma (Q37362634) (← links)
- Mechanism regulating proasthmatic effects of prolonged homologous beta2-adrenergic receptor desensitization in airway smooth muscle (Q37406409) (← links)
- Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma (Q37556546) (← links)
- Budesonide/formoterol combination in COPD: a US perspective (Q37805343) (← links)
- The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors (Q42429572) (← links)
- The preclinical toxicology of salmeterol hydroxynaphthoate (Q43134820) (← links)
- Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119. (Q45948093) (← links)
- Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD. (Q47966525) (← links)
- Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler (Q51146642) (← links)
- Budesonide/salmeterol in fixed-dose combination for the treatment of asthma (Q51602950) (← links)
- Insulin/IGF1 signalling mediates the effects of β -adrenergic agonist on muscle proteostasis and growth (Q64094105) (← links)
- Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness? (Q92373947) (← links)